King Pharmaceuticals®, Inc. Provides Updated Replay Information for Conference Call Regarding Proposed Acquisition of Alpharma Inc.

BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE:KG) today held a conference call at 10:00 AM ET to discuss its proposal to acquire Alpharma Inc. (NYSE:ALO) for $33.00 per share in cash.

MORE ON THIS TOPIC